Delivery Order SPE2DB22D2211-SPE2DB24FMJS0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,643.99 firm fixed-price delivery order contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract has an ultimate completion date of May 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,872.82 firm fixed-price delivery order contract is for the supply of 4 mg ondansetron orally disintegrating tablets. The contract has an ultimate completion date of November 15, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,805.20 firm fixed-price delivery order is for the supply of 4 mg ondansetron orally disintegrating tablets. The contract has a completion date of November 14, 2024 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,234.05 firm fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,999.76 firm fixed-price delivery order is for the supply of 4 mg Ondansetron orally disintegrating tablets. The contract has an ultimate completion date of April 2, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,898.97 firm-fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,774.56 fixed-price delivery order is for the supply of 4 mg ondansetron orally disintegrating tablets in quantities of 30 per bottle. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $42,433.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,114.30 firm fixed-price delivery order is for the supply of 4 mg ondansetron orally disintegrating tablets in packages of 30, with a completion date of December 12, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,305.60 firm-fixed-price delivery order is for the supply of 4 mg Ondansetron orally disintegrating tablets in 30-count bottles. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMJS0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,919.77 firm fixed-price delivery order contract is for the supply of 4 mg ondansetron orally disintegrating tablets. The contract has an ultimate completion date of December 14, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen plays a critical role in supplying essential medical products to federal government agencies, particularly within military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 12/13/23 |